Dublin, Ohio-based Cardinal Health, Inc. (CAH) manufactures and distributes pharmaceuticals, medical & laboratory products, ...
Cardinal Health CEO Jason Hollar recounted the company's "nice run" at the nation's largest annual healthcare industry conference. Cardinal Health Inc. raised its earnings outlook for fiscal 2025 ...
Argus analyst Kristina Ruggeri raised the firm’s price target on Cardinal Health (CAH) to $148 from $145 and keeps a Buy rating on the shares.
Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on Cardinal Health (CAH – Research Report). The associated price target was ...